Jim Simons’s China Pharma Holdings CPHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.96K | Buy |
11,418
+100
| +0.9% | +$84 | ﹤0.01% | 3204 |
|
|
2025
Q4 | $13.7K | Buy |
11,318
+700
| +7% | +$1.15K | ﹤0.01% | 3162 |
|
|
2025
Q3 | $20.7K | Buy |
+10,618
| New | +$18K | ﹤0.01% | 3424 |
|
|
2025
Q2 | – | Sell |
-4,610
| Closed | -$12.1K | – | 3600 |
|
|
2025
Q1 | $12.1K | Buy |
+4,610
| New | +$10.5K | ﹤0.01% | 3385 |
|
|
2023
Q4 | – | Sell |
-619
| Closed | -$5K | – | 3791 |
|
|
2023
Q3 | $5K | Sell |
619
-658
| -52% | -$8.01K | ﹤0.01% | 3601 |
|
|
2023
Q2 | $22K | Sell |
1,277
-2,130
| -63% | -$37.4K | ﹤0.01% | 3757 |
|
|
2023
Q1 | $66K | Buy |
3,407
+2,726
| +400% | +$111K | ﹤0.01% | 3597 |
|
|
2022
Q4 | $33K | Sell |
681
-48
| -7% | -$2.93K | ﹤0.01% | 3871 |
|
|
2022
Q3 | $47K | Buy |
729
+91
| +14% | +$8.98K | ﹤0.01% | 3774 |
|
|
2022
Q2 | $68K | Sell |
638
-71
| -10% | -$9.5K | ﹤0.01% | 3939 |
|
|
2022
Q1 | $138K | Sell |
709
-211
| -23% | -$44K | ﹤0.01% | 3733 |
|
|
2021
Q4 | $222K | Sell |
920
-481
| -34% | -$131K | ﹤0.01% | 3473 |
|
|
2021
Q3 | $391K | Buy |
1,401
+426
| +44% | +$151K | ﹤0.01% | 2982 |
|
|
2021
Q2 | $353K | Sell |
975
-40
| -4% | -$14.4K | ﹤0.01% | 3088 |
|
|
2021
Q1 | $426K | Sell |
1,015
-573
| -36% | -$247K | ﹤0.01% | 2971 |
|
|
2020
Q4 | $354K | Buy |
1,588
+131
| +9% | +$28.2K | ﹤0.01% | 2978 |
|
|
2020
Q3 | $266K | Sell |
1,457
-219
| -13% | -$50.5K | ﹤0.01% | 3035 |
|
|
2020
Q2 | $558K | Sell |
1,676
-224
| -12% | -$55.3K | ﹤0.01% | 2831 |
|
|
2020
Q1 | $479K | Buy |
1,900
+113
| +6% | +$29.8K | ﹤0.01% | 2778 |
|
|
2019
Q4 | $212K | Buy |
1,787
+324
| +22% | +$39.9K | ﹤0.01% | 3180 |
|
|
2019
Q3 | $179K | Sell |
1,463
-59
| -4% | -$8.06K | ﹤0.01% | 3172 |
|
|
2019
Q2 | $246K | Sell |
1,522
-36
| -2% | -$5.78K | ﹤0.01% | 3247 |
|
|
2019
Q1 | $258K | Buy |
1,558
+557
| +56% | +$82K | ﹤0.01% | 3143 |
|
|
2018
Q4 | $129K | Buy |
1,001
+19
| +2% | +$2.76K | ﹤0.01% | 3200 |
|
|
2018
Q3 | $100K | Sell |
982
-36
| -4% | -$4.23K | ﹤0.01% | 3243 |
|
|
2018
Q2 | $112K | Sell |
1,018
-147
| -13% | -$19.8K | ﹤0.01% | 3136 |
|
|
2018
Q1 | $185K | Buy |
1,165
+95
| +9% | +$17K | ﹤0.01% | 3193 |
|
|
2017
Q4 | $94K | Buy |
1,070
+185
| +21% | +$16.1K | ﹤0.01% | 3227 |
|
|
2017
Q3 | $77K | Buy |
885
+209
| +31% | +$20.7K | ﹤0.01% | 3100 |
|
|
2017
Q2 | $78K | Buy |
676
+337
| +99% | +$38.1K | ﹤0.01% | 3100 |
|
|
2017
Q1 | $44K | Buy |
339
+72
| +27% | +$9.13K | ﹤0.01% | 3148 |
|
|
2016
Q4 | $35K | Buy |
267
+27
| +11% | +$2.87K | ﹤0.01% | 3187 |
|
|
2016
Q3 | $26K | Buy |
240
+49
| +26% | +$6.28K | ﹤0.01% | 3282 |
|
|
2016
Q2 | $23K | Buy |
191
+3
| +2% | +$337 | ﹤0.01% | 3277 |
|
|
2016
Q1 | $16K | Sell |
188
-17
| -8% | -$1.28K | ﹤0.01% | 3334 |
|
|
2015
Q4 | $16K | Sell |
205
-13
| -6% | -$1.26K | ﹤0.01% | 3235 |
|
|
2015
Q3 | $22K | Sell |
218
-27
| -11% | -$3.27K | ﹤0.01% | 3108 |
|
|
2015
Q2 | $44K | Sell |
245
-19
| -7% | -$3.27K | ﹤0.01% | 3167 |
|
|
2015
Q1 | $45K | Sell |
264
-9
| -3% | -$1.55K | ﹤0.01% | 3086 |
|
|
2014
Q4 | $41K | Sell |
273
-36
| -12% | -$5.29K | ﹤0.01% | 2888 |
|
|
2014
Q3 | $39K | Buy |
309
+16
| +5% | +$2.31K | ﹤0.01% | 2723 |
|
|
2014
Q2 | $56K | Sell |
293
-23
| -7% | -$4.78K | ﹤0.01% | 2710 |
|
|
2014
Q1 | $80K | Buy |
316
+11
| +4% | +$3.04K | ﹤0.01% | 2725 |
|
|
2013
Q4 | $53K | Sell |
305
-38
| -11% | -$6.4K | ﹤0.01% | 2780 |
|
|
2013
Q3 | $48K | Sell |
343
-12
| -3% | -$1.39K | ﹤0.01% | 2744 |
|
|
2013
Q2 | $37K | Buy |
+355
| New | +$41.4K | ﹤0.01% | 2715 |
|
Other funds holding CPHI
EI
DB
Jim Simons's CPHI Position: Q1 2026 in Review
Jim Simons increased its China Pharma Holdings (CPHI) stake by 0.88% in Q1 2026, buying an estimated $84 and bringing the position to 11,418 shares worth $6.96K. The position accounts for ﹤0.01% of the portfolio, ranked #3204.
Jim Simons first reported a position in CPHI in Q2 2013 and has held it in 46 quarters since. The position peaked at $558K in Q2 2020. 6 funds tracked by Wall St. Rank hold CPHI as of Q1 2026.
- Jim Simons held 11,418 shares of China Pharma Holdings worth $6.96K as of Q1 2026.
- Jim Simons bought 100 China Pharma Holdings shares in Q1 2026, an estimated $84.
- China Pharma Holdings made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #3204 holding.
- Jim Simons first reported a position in China Pharma Holdings in Q2 2013 and has held it in 46 quarters since.
- Jim Simons's China Pharma Holdings position peaked at $558K in Q2 2020.
- 6 funds tracked by Wall St. Rank held China Pharma Holdings as of Q1 2026.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.